Abdelmoez Hyaluronic Acid Dermal Filler Scoring System
- 1 Al-Hokail, Khobar, KSA
Abstract
Introduction: Dermal fillers industry is ever-expanding. Tens, if not hundreds, of brands are available to purchase legally or illegally. I have attempted in this paper to develop a scoring system for Hyaluronic acid dermal fillers that makes an injector’s verdict objective, fair and unbiased, and injection experience safer. Theoretically speaking, the worst filler will have, at least, - 12 score and the best will have a score of 34 points. Some scoring points do not exist in any filler, suggesting hints to improve all brands. Objectives: To build a Hyaluronic acid dermal filler scoring system that deals with what the injector can easily read, see or experience on their own without using sophisticated technologies or the need to understand or estimate the physics or the chemistry behind the filler. Using a scoring system that depends more on objective than subjective findings will be easy and unbiased to apply, more practical. The scoring system structure should be holistic rather than being only results centered and more focused on safety.
- (2019) Dermal Fillers Market Size, Share and Industry Analysis by Product (Biodegradable, Non-Biodegradable), by Ingredient (Hyaluronic Acid, Calcium Hydroxylapatite Poly-L-lactic Acid, PMMA (Poly (methyl methacrylate)), Fat Fillers), by Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement. Restoration of Volume/Fullness) and Regional Forecast 2019-2026. https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939
- U.S. Food and Drug Administration (2008) What We Do. https://www.fda.gov/about-fda/what-we-do
- Henderson, D. (2006) Panel: FDA Needs More Power, Funds. The Boston Globe.
- Committee on the Assessment of the US Drug Safety System (2006) The Future of Drug Safety: Promoting and Protecting the Health of the Public. National Academy of Medicine, Washington DC.
- Mundy, A. and Favole, J.A. (2009) FDA Scientists Ask Obama to Restructure Drug Agency. The Wall Street Journal.
- Williams, R., Scharff, R. and Bieler, D. (2010) Food Safety in the 21st Century. Mercatus on Policy. 71.
- Jonathan (2016) The Lack of EpiPen Competitors Is the FDA’s Fault—Jonathan Newman.
- Zuckerman, D.M., Brown, P. and Nissen, S.E. (2011) Medical Device Recalls and the FDA Approval Process. Archives of Internal Medicine, 171, 1006-1011. https://doi.org/10.1001/archinternmed.2011.30
- Narins, R.S., Brandt, F., Leyden, J., Lorenc, Z.P., Rubin, M., et al. (2003) A Randomized, Double-Blind, Multicenter Comparison of the Efficacy and Tolerability of Restylane versus Zyplast for the Correction of Nasolabial Folds. Dermatologic Surgery, 29, 588-595. https://doi.org/10.1046/j.1524-4725.2003.29150.x
- Day, D.J., Littler, C.M., Swift, R.W. and Gottlieb, S. (2004) The Wrinkle Severity Rating Scale: A Validation Study. American Journal of Clinical Dermatology, 5, 49-52. https://doi.org/10.2165/00128071-200405010-00007
- Kane, M.A.C., Lorenc, Z.P., Lin, X.M. and Smith, S.R. (2012) Validation of a Lip Fullness Scale for Assessment of Lip Augmentation. Plastic and Reconstructive Surgery, 129, 822e-828e. https://doi.org/10.1097/PRS.0b013e31824a2df0
- Werschler, W.P., Fagien, S., Thomas, J., Paradkar-Mitragotri, D., Rotunda, A. and Beddingfield III, F.C. (2015) Development and Validation of a Photographic Scale for Assessment of Lip Fullness. Aesthetic Surgery Journal, 35, 294-307. https://doi.org/10.1093/asj/sju025